G Lotti
About
In The Last Decade
G Lotti
48 papers receiving 594 citations
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 152
- Molecular Biology 144
- Cardiology and Cardiovascular Medicine 128
- Cellular and Molecular Neuroscience 102
- Immunology 69
Countries citing papers authored by G Lotti
This map shows the geographic impact of G Lotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Lotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Lotti more than expected).
Fields of papers citing papers by G Lotti
This network shows the impact of papers produced by G Lotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Lotti. The network helps show where G Lotti may publish in the future.
Co-authorship network of co-authors of G Lotti
This figure shows the co-authorship network connecting the top 25 collaborators of G Lotti. A scholar is included among the top collaborators of G Lotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Lotti. G Lotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 14 | |
| 3 | 19 | |
| 4 | [FREQUENCY OF PRIMARY AND SECONDARY TUMORS OF THE HEART. (DRAWN FROM STATISTICAL FINDINGS COLLECTED IN THE INSTITUTE OF PATHOLOGIC ANATOMY AND HISTOLOGY OF THE UNIVERSITY OF ROME FOR THE 10 YEAR PERIOD 1953-1962)]. | 3 |
| 5 | 2 | |
| 6 | 21 | |
| 7 | [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance]. | 7 |
| 8 | Clinical perspectives in endogenous opioids peptides | 1 |
| 9 | 25 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 31 | |
| 13 | 1 | |
| 14 | 6 | |
| 15 | 12 | |
| 16 | 6 | |
| 17 | 19 | |
| 18 | 7 | |
| 19 | 11 | |
| 20 | Depistage du cancer. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.